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Abstract: Introduction: Neonatal
sepsis is a major cause of mortal-
ity in developing countries. Accu-
rate and quick diagnosis are diffi-
cult because clinical presentation
are non-specific, bacterial cultures
are time-consuming and other
laboratory tests lack sensitivity
and specificity. Serum procalci-
tonin (PCT) has been proposed as
an early marker of infections in
neonates.
Objectives: This study investi-
gated the value of PCT in the di-
agnosis of Neonatal Sepsis.
Methods: Neonates undergoing
sepsis evaluation  at the Special
Baby Care Unit, Federal Medical
Centre, Abeokuta, Nigeria be-
tween January and April 2013
were included. Blood samples
were obtained for white cell
count, blood cultures, serum CRP
and PCT analysis. Neonates were
categorised into Proven Sepsis,
Suspected Sepsis and Clinical
Sepsis groups on the basis of
laboratory findings and risk fac-
tors. A control group with no
clinical and biological data of
infection was also included. Pre-
dictive values and area under the
receiver operating characteristic
curve (AUC) of PCT were evalu-
ated.
Result: Of the 85 neonates, 19
(22.4%) had positive blood cul-
ture. PCT level was significantly
higher in neonates in all sepsis
groups in comparison with those in
the control group (P< 0.05). At a
cut-off of 0.5 ng/ml, the negative
predictive value (NPV) of PCT
was 80% and the positive predic-
tive value (PPV) 39%. There were
no significant statistical difference
between the AUC values of PCT
in Early onset and Late onset sep-
sis, as well between AUC in Pre-
term and term cases. A higher per-
centage of neonates who died
(96%) had elevated PCT levels
compared to those who survived
(46%).
Conclusion: These findings sup-
port the usefulness of the PCT in
diagnosis of Neonatal sepsis.
Keywords: Neonatal Sepsis, Diag-
nosis, Procalcitonin, Receiver
Operating Characteristic Curve
tain blood sample for serial blood culture from infants3.
Therefore, there is need for newer diagnostics methods
to obtain a rapid indication of the infectious status of
neonates with suspected sepsis. In recent years, the
search for diagnostic tests for sepsis in newborn infants
has turned to cytokines as well as to other substances
associated with the inflammatory response, in some
cases induced by cytokines, as possible indicators of
infection.
Among them, serum procalcitonin (PCT) is one of the
most promising4. PCT, a 116-amino-acid protein with a
molecular weight of 13 KDa, is the precursor in the syn-
thesis of calcitonin (CT). Firstly demonstrated to in-
crease at the onset of bacterial infection and sepsis by
Introduction
Neonatal sepsis is one of the important causes of neona-
tal morbidity and mortality particularly in the develop-
ing countries1. An early diagnosis of neonatal septicae-
mia helps the clinician in instituting antibiotic therapy at
the earliest, thereby reducing the mortality rates in the
neonates. Early recognition and diagnosis of neonatal
sepsis are difficult because of its variable and non-
specific clinical presentation. Isolation of the causative
microorganisms by using blood culture has been the
gold standard method for its diagnosis. However, as
pathogens in blood cultures are only detected in approxi-
mately 25% of patients, the sensitivity of blood culture
is suspected to be low2. Besides, it is impractical to ob-
Assicot et al in 19935, this acute phase reactant has the
characters of acute phase proteins, hormones and cyto-
kines. Serum PCT concentration rises 2-4 hours after
endotoxin injection, reaches its peak level right after 6
hours, maintains a plateau through 8 to 24 hours6 and
decreases to its normal level if the infection stimulus
stops. It has been reported to be a reliable marker for
severe bacterial infections and sepsis5.
Procalcitonin levels are undetectable in healthy indi-
viduals and slightly increased in severe viral infections
and non infectious inflammatory responses7. The results
of recent studies suggest the usefulness of PCT for early
diagnosis of neonatal sepsis8, 9, although other investiga-
tors have observed lack of accuracy for this marker10.
This study aims at evaluating procalcitonin as an early
or first line marker in the diagnosis of neonatal septice-
mic infection.
Methods
In this prospective cohort study, all neonates undergoing
evaluation for sepsis at the Federal Medical Centre,
Abeokuta between January and April 2013 were eligible
for inclusion. Written consent was obtained from the
parents/guardians of all the investigated neonates. Ethi-
cal clearance was obtained from the Research and Ethi-
cal Clearance Committee of the hospital. For each baby,
a written informed consent was also obtained from the
parent(s) or guardian. Neonates suspected on clinical
grounds to have sepsis were included in the study at the
point of admission or while on admission in the hospital.
Exclusion criteria were obvious congenital anomalies or
prior antibiotic therapy. The clinical criteria for the
evaluation of sepsis were: Maternal risk factor such as
fever, prolonged rupture of amniotic membrane >24hr;
Neonatal history: low birth weight (< 2500 grams), pre-
term birth (<37 weeks); Signs and symptoms of sepsis:
Respiratory distress, refusal to feed, convulsion, poor
cry, abdominal distension, high pitched cry, irritability,
apnea, and palor.
A sepsis work-up which included white cell count
(WCC), blood culture and PCT and CRP level determi-
nation was done for all neonates enrolled. Procalcitonin
level was determined using the BRAHMS PCT-Q test
kit, a semi-quantitative detection of PCT. At a PCT con-
centration ≥ 0.5 ng/ml, this sandwich complex can be
seen as a reddish band. The colour intensity of the band
of a PCT Q test kit   is directly proportional to the PCT
concentration of the sample and is related to the follow-
ing PCT concentration ranges:< 0.5 ng/ml (At PCT <
0.5 ng/ml - Systemic infection/sepsis is not likely11), ≥
0.5 ng/ml (At PCT > 0.5 and < 2 ng/ml- Moderate risk
for progression to severe systemic infection11), ≥ 2 ng/
ml, (PCT> 2 and < 10 ng/ml- High risk for progression
to severe systemic infection11), ≥ 10 ng/ml. (PCT > 10
ng/ml-High likelihood of severe sepsis or septic shock11)
According to clinical symptoms of sepsis, microbiologic
and laboratory results, neonates classified in to different
categories of infection (similar to previous studies by
Magudumana et al., 200013,Whiteet al., 200721and Bal-
lot et al., 200412) as follows: (a) Group І (proven sepsis):
Clinical signs and symptoms with positive blood culture.
(b) Group ІІ (suspected sepsis): Clinical signs and symp-
toms with negative bacterial culture but with positive
screening test (CRP, WCC). (c) Group III (clinical sep-
sis): Clinical signs and symptoms with negative bacte-
rial culture and negative screening test. Patients were
placed into 3 groups rather than just present and absent
infection as it is acknowledged that some babies with
sepsis will have negative blood cultures. Excluding the
patients with possible infection would result in the po-
tential exclusion of some patients with actual infection12.
A control group consisting of 12 healthy neonates with
no clinical and biological data of infection in an immu-
nization clinic prior to immunization was also included
in the study.
Data was analyzed using SPSS for windows version
17.0. Statistical test between variables was done using
Chi-squared test (χ2). Where the numbers in a cell was
less than five, a Fisher's exact test was used. Differences
between groups were assessed by z-test. A p value <0.05
was considered significant for all statistical tests. Diag-
nostic efficiency was defined by sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV). In line with Ballot et al., 200412, Group I
and Group II  patients were regarded as positive,
whereas Group III group was regarded as negative. Re-
ceiver operating characteristic (ROC) curves were also
constructed. . The closer the ROC curve is to the upper
left corner, the higher the overall accuracy of the test14.If
the p-value of an ROC curve is less than 0.05 (P<0.05),
there is evidence that the laboratory test does have an
ability to distinguish between the two groups.
Results
Patients’Characteristics
There were 180 neonates admitted during the study
period and 105 of them met the inclusion criteria.
Twenty of these 105 neonates were excluded from the
study. The study group included 85 neonates with sus-
pected (presumed and probable) neonatal sepsis (Table
1).  Of these 85 neonates, 45 were females (52.1%) and
40 were males (47.9%). The mean age of the partici-
pants at enrolment was 3.4±0.5 days and the mean
weight was 2.5± 0.8 Kg.  Blood culture was positive in
19 (22.4%) of the neonates. The sepsis grading and the
differences between sepsis groups are shown in Table 1.













































Fifty five (64.7%) of the patients had elevated PCT val-
ues (>0.5ng/ml). Elevated PCT levels were recorded in
84.2%, 66.7%, 57.4% and 16.7% of neonates in the
proven, suspected, clinical and control groups respec-
tively.
Fig 1: Procalcitonin Levels In Sepsis Groups
PCT level was significantly higher (PCT >0.5) in infants
in all sepsis groups (Proven, Suspected or Clinical) com-
pared with the control group (p-value < 0.05) More than
two-third of patients with proven sepsis and more than
half of patients with suspected sepsis had PCT values
indicating a high risk for progression to severe systemic
infection or septic shock. Majority of patients with clini-
cally suspected sepsis had PCT values indicating a low
or moderate risk for progression to severe systemic in-
fection.
Sensitivity, Specificity, PPV and NPV
As cut off values increased, Specificity, PPV, and FN
increased while Sensitivity and FP decreased. Overall,
using a cut-off of 0.5 ng/ml, the NPV of PCT was 69%
and the PPV 50%. (Table 2).
Table 2: Predictive Values For Various Cut-Offs of PCT
Receiver operating characteristics (ROC) analysis
The ROC AUC for the whole group was 0.686 (Fig: 2).
No significant statistical difference was found between
the AUC values of PCT in Preterm or Term cases.
Fig 2: ROC Curve for all
neonates (Area under the
curve = 0.686)
Similarly, there was no statistically significant differ-




Sensitivity 75.7 62.2 27.0
Specificity 41.7 77.1 91.7
PPV 50.0 67.7 71.4
NPV 69.0 72.6 62.0
FP 58.3 22.9 8.3
FN 24.3 37.8 73.0
Fig 3a and b: ROC curves comparing the sensitivity and specificity of
serum PCT in neonates with EONS and LONS (Area under the curves
= 0.662 and 0.658 for EONS and LONS respectively).
(a)                                                   (b)
A higher proportion of neonates with respiratory distress
and convulsion compared to neonates without these
sign/symptom had elevated PCT levels. These differ-
ences were statistically significant. (p<0.05) Also, a
higher percentage of neonates who died compared to
neonates who were discharged had elevated PCT levels
and the difference was statistically significant. (p<0.000)
Fig 4: ROC curves comparing the sensitivity and specificity of serum
PCT in Preterm and Term neonates (Area under the curves = 0.671
and 0.722 respectively).
(a)                                             (b)
Table 3: Procalcitonin Levels in relation to Clinical Findings













































































































*Ten of the neonates were discharged against medical advice and were excluded
from this analysis
Discussion
Neonatal sepsis still remains a diagnostic and treatment
challenge for the neonatal health care providers. This
challenge leads to the over treatment of large number of
neonates who present with clinical suspicion of sepsis15.
In recent years measurement of procalcitonin and other
inflammatory mediators have been reported as sensitive
parameters for the early diagnosis of neonatal sepsis and
evaluating its outcome16. The aim of this study was to
evaluate PCT as diagnostic marker for neonatal sepsis.
The incidence of culture-proven sepsis was low (22%).
This is consistent with the reports of incidence of 20%
and 25.7% by Adeleke and Belonwu, 200617, and Naher
and Khamel, 201318 respectively. This corroborates pre-
vious reports on the low sensitivity of blood culture in
neonatal sepsis2. PCT levels were high in the neonates
with proven and suspected sepsis cases. This finding
was similar with reports of some studies19, 20. Three neo-
nates in the proven sepsis group had PCT lower than
0.5ng/ml. These neonates were preterm and two had
very low birth weights.  Two of the 12 neonates in the
control group had procalcitonin higher than 0.5 ng/ml.
This may be due to physiological increase of procalci-
tonin, reported up to 21-48 hr postpartum, even in the
absence of infection. The postnatal increase of PCT ob-
served in the healthy neonate with peak values at 24 h of
age most likely represents endogenous synthesis21.
In this study, at a cut-off point of 0.5ng/ml, the sensitiv-
ity and specificity, PPV and NPV of PCT in neonatal
sepsis was found to be 89% and 23%, 84% and 83%
respectively for proven infection. This high sensitivity
and NPV of PCT is consistent with the reports of Ballot
et al., 200412in South Africa and Sucilathangam, et al.,
in 201220 in India. White, et al., in 200722in South Africa
recorded similar report of NPV of 80%, but a lower sen-
sitivity of 48%. NPV and Sensitivity increased to 100%
and specificity 56% as cut off values increased to 10
while PPV dropped to 21%.In the study of White, et al.,
in 200722, increased cut-off value (10.1 ng/ml) had no
effect on the NPV, worsened the sensitivity (98% v.
22%, respectively), but improved the PPV (78% v. 79%,
respectively), and the specificity (74%v.98%).
ROC analysis for PCT had an area under the curve
(AUC) of 0.686 which is similar to reports of White, et
al., 200722, where ROC analysis had an area of 0.631.
Boraey, et al., 201223 reported an AUC value of 0.92 for
PCT at a cut off value of 1.3ng/ml. AUC values were
0.662 and 0.658 for Preterm and Term neonates respec-
tively without any significant statistical difference. This
is in agreement with the reports of White et al.,
200722.Also, no significant statistical difference was
found between the AUC values of PCT in EONS and
LONS cases. This suggests that the PCT seems to be
equally accurate for the diagnosis of neonatal sepsis in
preterm and term neonates; as well as in EONS and
LONS cases.
The result from this study suggests PCT as a good pre-
dictor of mortality as almost all neonates who died
(96.3%) had elevated PCT. This is in agreement with
Adib, et al., 201224.
Limitation
The overall diagnostic value of PCT for neonatal sepsis
could probably be improved if PCT was measured more
precisely with an ultrasensitive PCT assay instead of the
semiquantitative assay used in this study. Another limi-
tation of our study may be the modest prevalence culture
proven sepsis in this study, which, of course, directly
influences the values of PCT as a biomarker for neonatal
sepsis. With the use of more sophisticated diagnostic
techniques like PCR, a causative bacterial micro-
organism might have been demonstrated in a subset of
neonates allocated to the group “suspected sepsis.” Also,
a better comparism would have been achieved using a
sufficient population of control. The population of con-
trol in this study was limited.
Conclusion
These findings support the usefulness of the PCT to sup-
port an early diagnosis of neonatal sepsis. Results from
this study suggest that any increase in PCT in an ill neo-
nate suggests the possibility of a septicemic infection.
However, PCT is not sufficiently reliable to be the sole
marker of neonatal sepsis and  would be useful as part of
a full sepsis evaluation. A negative PCT on presentation
is not exclusively sufficient to rule out sepsis, but needs
to be evaluated further. PCT is also of great advantages
where prediction of severity and mortality is concerned.
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